Status:

UNKNOWN

The Effect of Nexium on Transmucosal Esophageal Leak

Lead Sponsor:

Main Line Health

Collaborating Sponsors:

AstraZeneca

Sharpe-Strumia Research Foundation

Conditions:

Reflux

Esophagitis

Eligibility:

All Genders

18+ years

Phase:

PHASE1

Brief Summary

In a related study, the investigators have found evidence that patients with Barrett's esophagus have a leak for oral sucrose to leave their upper gastrointestinal tract, enter the blood, and be filte...

Detailed Description

In a related study, we have found evidence that patients with Barrett's esophagus have a leak for oral sucrose to leave the lumen of their upper gastrointestinal tract, enter the blood, and be filtere...

Eligibility Criteria

Inclusion

  • Patients presenting to a general practitioner / internist with symptoms of GERD defined as:
  • Heartburn - uncomfortable, rising, burning sensation behind the breastbone
  • Regurgitation of gastric acid or sour contents into the mouth
  • Chest pain atypical for cardiac ischemia and more suggestive of GERD
  • Symptoms for more than three weeks with no concurrent use of PPI's or H-2 blockers during that time period
  • A score greater than or equal to 5 on the AstraZeneca RDQ

Exclusion

  • Any patients presenting with alarm symptoms (GI bleeding, dysphagia, weight loss, abdominal mass, lymphadenopathy, or recurrent vomiting)
  • Diabetes (type I or II)
  • Renal insufficiency defined as creatinine \>1.6
  • Under 18 years of age
  • Prior surgery on esophagus, stomach or duodenum
  • History of gastric/duodenal ulcers
  • History of H. pylori
  • Known history of Barrett's esophagus (recruited to parallel study)
  • On Coumadin or Heparin therapy
  • Chronic upper abdominal pain more consistent with dyspepsia or other diagnoses
  • Noncompliant patients

Key Trial Info

Start Date :

January 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

January 1 2006

Estimated Enrollment :

35 Patients enrolled

Trial Details

Trial ID

NCT00216788

Start Date

January 1 2006

End Date

January 1 2006

Last Update

March 16 2010

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Lankenau Hospital

Wynnewood, Pennsylvania, United States, 19096

The Effect of Nexium on Transmucosal Esophageal Leak | DecenTrialz